European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage

The optimal blood pressure (BP) management in acute ischaemic stroke (AIS) and acute intracerebral haemorrhage (ICH) remains controversial. These European Stroke Organisation (ESO) guidelines provide evidence-based recommendations to assist physicians in their clinical decisions regarding BP management in acute stroke. The guidelines were developed according to the ESO standard operating procedure and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. The working group identified relevant clinical questions, performed systematic reviews and meta-analyses of the literature, assessed the quality of the available evidence, and made specific recommendations. Expert consensus statements were provided where insufficient evidence was available to provide recommendations based on the GRADE approach. Despite several large randomised-controlled clinical trials, quality of evidence is generally low due to inconsistent results of the effect of blood pressure lowering in AIS. We recommend early and modest blood pressure control (avoiding blood pressure levels >180/105 mm Hg) in AIS patients undergoing reperfusion therapies. There is more high-quality randomised evidence for BP lowering in acute ICH, where intensive blood pressure lowering is recommended rapidly after hospital presentation with the intent to improve recovery by reducing haematoma expansion. These guidelines provide further recommendations on blood pressure thresholds and for specific patient subgroups. There is ongoing uncertainty regarding the most appropriate blood pressure management in AIS and ICH. Future randomised-controlled clinical trials are needed to inform decision making on thresholds, timing and strategy of blood pressure lowering in different acute stroke patient subgroups.

[1]  Correction to: Blood Pressure After Endovascular Thrombectomy: Modeling for Outcomes Based on Recanalization Status. , 2021, Stroke.

[2]  Ana Catarina Fonseca,et al.  European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke , 2021, European stroke journal.

[3]  J. Broderick,et al.  Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial , 2021, The Lancet Neurology.

[4]  M. Woodward,et al.  Intensive versus guideline‐recommended blood pressure reduction in acute lacunar stroke with intravenous thrombolysis therapy: The ENCHANTED trial , 2020, European journal of neurology.

[5]  M. Woodward,et al.  Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial , 2020, Journal of hypertension.

[6]  A. Alexandrov,et al.  Blood pressure excursions in acute ischemic stroke patients treated with intravenous thrombolysis , 2020, Journal of hypertension.

[7]  J. Broderick,et al.  Blood Pressure Target in Acute Stroke to Reduce HemorrhaGe After Endovascular Therapy: The Randomized BP TARGET Study Protocol , 2020, Frontiers in Neurology.

[8]  Fang Yang,et al.  Controlling Hypertension After Severe Cerebrovascular Event (CHASE): A randomized, multicenter, controlled study , 2020, International journal of stroke : official journal of the International Stroke Society.

[9]  C. Molina,et al.  Spontaneous systolic blood pressure drop early after mechanical thrombectomy predicts dramatic neurological recovery in ischaemic stroke patients , 2020, European stroke journal.

[10]  J. Goldstein,et al.  Ultra‐Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral Hemorrhage , 2020, Annals of neurology.

[11]  Michele H Johnson,et al.  Fixed Compared With Autoregulation-Oriented Blood Pressure Thresholds After Mechanical Thrombectomy for Ischemic Stroke , 2020, Stroke.

[12]  L. Uhlmann,et al.  Blood Pressure Thresholds and Neurologic Outcomes After Endovascular Therapy for Acute Ischemic Stroke: An Analysis of Individual Patient Data From 3 Randomized Clinical Trials. , 2020, JAMA neurology.

[13]  A. Alexandrov,et al.  Association of Blood Pressure With Outcomes in Acute Stroke Thrombectomy , 2020, Hypertension.

[14]  T. Short,et al.  A pilot randomised controlled trial of the management of systolic blood pressure during endovascular thrombectomy for acute ischaemic stroke , 2019, Anaesthesia.

[15]  A. Alexandrov,et al.  Blood pressure reduction and outcome after endovascular therapy with successful reperfusion: a multicenter study , 2019, Journal of NeuroInterventional Surgery.

[16]  Eung-Gyu Kim,et al.  Therapeutic-induced hypertension in patients with noncardioembolic acute stroke , 2019, Neurology.

[17]  A. Alexandrov,et al.  Mortality Risk in Acute Ischemic Stroke Patients With Large Vessel Occlusion Treated With Mechanical Thrombectomy , 2019, Journal of the American Heart Association.

[18]  A. Spiotta,et al.  Impact of reperfusion pump power on technical and clinical outcomes after direct aspiration thrombectomy (ADAPT) , 2019, Journal of NeuroInterventional Surgery.

[19]  E. Gayat,et al.  A 10% blood pressure drop from baseline during mechanical thrombectomy for stroke is strongly associated with worse neurological outcomes , 2019, Journal of NeuroInterventional Surgery.

[20]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[21]  F. de Leeuw,et al.  Multicentre Randomised trial of Acute Stroke treatment in the Ambulance with a nitroglycerin Patch (MR ASAP): study protocol for a randomised controlled trial , 2019, Trials.

[22]  C. Matouk,et al.  Decreases in Blood Pressure During Thrombectomy Are Associated With Larger Infarct Volumes and Worse Functional Outcome. , 2019, Stroke.

[23]  Peter J. Godolphin,et al.  Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke ( RIGHT-2 ) : an ambulance-based , randomised , sham-controlled , blinded , phase 3 trial , 2019 .

[24]  J. Wardlaw,et al.  It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis , 2019, Stroke and Vascular Neurology.

[25]  M. Mazighi,et al.  European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE) , 2019, European stroke journal.

[26]  U. Fischer,et al.  Blood pressure lowering in acute ischaemic stroke thrombolysis , 2019, The Lancet.

[27]  A. Alexandrov,et al.  Association of Elevated Blood Pressure Levels with Outcomes in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis: A Systematic Review and Meta-Analysis , 2019, Journal of stroke.

[28]  Michael T. McManus,et al.  Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data , 2019, The Lancet Neurology.

[29]  S. M. Park,et al.  Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. , 2019, Lancet.

[30]  V. Feigin,et al.  Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries , 2018, European stroke journal.

[31]  C. Anderson,et al.  Early Manipulation of Arterial Blood Pressure in Acute Ischemic Stroke (MAPAS): Results of a Randomized Controlled Trial , 2018, Neurocritical Care.

[32]  Y. Fujii,et al.  Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data , 2018 .

[33]  Michael D Hill,et al.  eTICI reperfusion: defining success in endovascular stroke therapy , 2018, Journal of NeuroInterventional Surgery.

[34]  P. Bath,et al.  Blood Pressure in Acute Stroke: To Treat or Not to Treat: That Is Still the Question. , 2018, Stroke.

[35]  A. Alexandrov,et al.  Evaluation of Acute Kidney Injury and Mortality After Intensive Blood Pressure Control in Patients With Intracerebral Hemorrhage , 2018, Journal of the American Heart Association.

[36]  E. Lindsay Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct , 2018 .

[37]  N. Juul,et al.  Effect of General Anesthesia and Conscious Sedation During Endovascular Therapy on Infarct Growth and Clinical Outcomes in Acute Ischemic Stroke: A Randomized Clinical Trial , 2018, JAMA neurology.

[38]  S. Gosselin,et al.  Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. , 2018, CJEM.

[39]  Ana Catarina Fonseca,et al.  European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre‐hospital management of stroke , 2018, European journal of neurology.

[40]  W. Powers,et al.  2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2018, Stroke.

[41]  L. Uhlmann,et al.  Predictors of symptomatic intracranial haemorrhage in off‐label thrombolysis: an analysis of the Safe Implementation of Treatments in Stroke registry , 2018, European journal of neurology.

[42]  A. Alexandrov,et al.  Blood pressure levels post mechanical thrombectomy and outcomes in non-recanalized large vessel occlusion patients , 2018, Journal of NeuroInterventional Surgery.

[43]  T. Robinson,et al.  Managing high blood pressure during acute ischemic stroke and intracerebral hemorrhage , 2017, Current opinion in neurology.

[44]  Salil Gupta,et al.  Randomized trial to assess safety and clinical efficacy of intensive blood pressure reduction in acute spontaneous intracerebral haemorrhage. , 2017, Medical journal, Armed Forces India.

[45]  Y. Huang,et al.  Efficacy of Antihypertensive Therapy in the Acute Stage of Cerebral Infarction - A Prospective, Randomized Control Trial. , 2018, Acta Cardiologica Sinica.

[46]  C. Enzinger,et al.  Increased middle cerebral artery mean blood flow velocity index after stroke thrombectomy indicates increased risk for intracranial hemorrhage , 2017, Journal of NeuroInterventional Surgery.

[47]  L. Wilkins Mortality and Disability According to Baseline Blood Pressure in Acute Ischemic Stroke Patients Treated by Thrombectomy: A Collaborative Pooled Analysis , 2017, Journal of the American Heart Association.

[48]  Eric E. Smith,et al.  Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke , 2017, European Heart Journal.

[49]  A. Alexandrov,et al.  Blood pressure levels post mechanical thrombectomy and outcomes in large vessel occlusion strokes , 2017, Neurology.

[50]  S. Greenberg,et al.  Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial , 2017, JAMA neurology.

[51]  H. Mattle,et al.  Blood Pressure in Acute Stroke: Still No Answer for Management. , 2017, Stroke.

[52]  Yeong-Bae Lee,et al.  The role of phenylephrine in patients with small deep subcortical infarct and progressive weakness , 2017, Journal of the Neurological Sciences.

[53]  M. Hellström,et al.  General Anesthesia Versus Conscious Sedation for Endovascular Treatment of Acute Ischemic Stroke: The AnStroke Trial (Anesthesia During Stroke) , 2017, Stroke.

[54]  M. Fusco,et al.  Systolic Blood Pressure Within 24 Hours After Thrombectomy for Acute Ischemic Stroke Correlates With Outcome , 2017, Journal of the American Heart Association.

[55]  Hester F. Lingsma,et al.  Baseline Blood Pressure Effect on the Benefit and Safety of Intra-Arterial Treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands) , 2017, Stroke.

[56]  J. Wardlaw,et al.  Continuing or Temporarily Stopping Prestroke Antihypertensive Medication in Acute Stroke: An Individual Patient Data Meta-Analysis , 2017, Hypertension.

[57]  Ricardo P Nogueira,et al.  Even Small Decreases in Blood Pressure during Conscious Sedation Affect Clinical Outcome after Stroke Thrombectomy: An Analysis of Hemodynamic Thresholds , 2017, American Journal of Neuroradiology.

[58]  K. Uchino,et al.  Timeline of blood pressure changes after intra-arterial therapy for acute ischemic stroke based on recanalization status , 2015, Journal of NeuroInterventional Surgery.

[59]  Ming Liu,et al.  Perioperative Antihypertensive Treatment in Patients With Spontaneous Intracerebral Hemorrhage , 2017, Stroke.

[60]  G. Guyatt,et al.  Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group. , 2016, Journal of clinical epidemiology.

[61]  L. Uhlmann,et al.  Effect of Conscious Sedation vs General Anesthesia on Early Neurological Improvement Among Patients With Ischemic Stroke Undergoing Endovascular Thrombectomy: A Randomized Clinical Trial. , 2016, JAMA.

[62]  Katherine C. Wurlitzer Prehospital Systolic Blood Pressure is Higher in Acute Stroke Compared with Stroke Mimics , 2016 .

[63]  P. Bath,et al.  Early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in the Scandinavian Candesartan Acute Stroke Trial (SCAST) , 2016, Journal of hypertension.

[64]  M. Lansberg,et al.  Blood pressure management in acute stroke , 2016, Stroke and Vascular Neurology.

[65]  A. Martins,et al.  Recanalization Modulates Association Between Blood Pressure and Functional Outcome in Acute Ischemic Stroke , 2016 .

[66]  J. Wardlaw,et al.  Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[67]  A. Alexandrov,et al.  Admission systolic blood pressure and outcomes in large vessel occlusion strokes treated with endovascular treatment , 2016, Journal of NeuroInterventional Surgery.

[68]  A. Demchuk,et al.  Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.

[69]  C. Anderson,et al.  Effect of Treatment Delay, Stroke Type, and Thrombolysis on the Effect of Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Acute Stroke: A Systematic Review and Meta-Analysis of Individual Patient from Randomised Trials , 2016, Stroke research and treatment.

[70]  S. Pocock,et al.  Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis , 2016, Stroke.

[71]  I. Surakka,et al.  Post‐thrombolytic blood pressure and symptomatic intracerebral hemorrhage , 2015, European journal of neurology.

[72]  P. Sandercock,et al.  Effects of Blood Pressure and Blood Pressure–Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke , 2015, Stroke.

[73]  J. Wardlaw,et al.  Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial , 2015, Stroke.

[74]  S. Ricksten,et al.  Hypotension During Endovascular Treatment of Ischemic Stroke Is a Risk Factor for Poor Neurological Outcome , 2015, Stroke.

[75]  T. Steiner,et al.  European Stroke Organisation (ESO) Guidelines for the Management of Temperature in Patients with Acute Ischemic Stroke , 2015, International journal of stroke : official journal of the International Stroke Society.

[76]  H. Diener,et al.  The European Stroke Organisation Guidelines: a standard operating procedure , 2015, International journal of stroke : official journal of the International Stroke Society.

[77]  L. Wilkins Intensive blood pressure reduction in acute intracerebral hemorrhage: A meta-analysis , 2015, Neurology.

[78]  C. Anderson,et al.  Timing of Blood Pressure Lowering in Acute Ischemic Stroke , 2015, Current Atherosclerosis Reports.

[79]  Stephanie Oberfoell Prehospital Use of Magnesium Sulfate as Neuroprotection in Acute Stroke , 2015 .

[80]  P. Bath,et al.  Effects of Blood Pressure Lowering in Patients with Acute Ischemic Stroke and Carotid Artery Stenosis , 2015, International journal of stroke : official journal of the International Stroke Society.

[81]  Eric E. Smith,et al.  Randomized assessment of rapid endovascular treatment of ischemic stroke. , 2015, The New England journal of medicine.

[82]  P. Bath,et al.  Effects of Blood Pressure–Lowering Treatment in Different Subtypes of Acute Ischemic Stroke , 2015, Stroke.

[83]  R. Conwit,et al.  Prehospital use of magnesium sulfate as neuroprotection in acute stroke. , 2015, The New England journal of medicine.

[84]  D. Kang,et al.  Modest Blood Pressure Reduction with Valsartan in Acute Ischemic Stroke: A Prospective, Randomized, Open-Label, Blinded-End-Point Trial , 2015, International journal of stroke : official journal of the International Stroke Society.

[85]  Pia LöwhagenHendén Response to Letter Regarding Article, “Hypotension During Endovascular Treatment of Ischemic Stroke Is a Risk Factor for Poor Neurological Outcome” , 2015 .

[86]  P. Bath,et al.  Blood Pressure–Lowering Treatment With Candesartan in Patients With Acute Hemorrhagic Stroke , 2014, Stroke.

[87]  D. Krieger,et al.  European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage , 2014, International journal of stroke : official journal of the International Stroke Society.

[88]  P. Talke,et al.  Expert Consensus Statement : Anesthetic Management of Endovascular Treatment for Acute Ischemic Stroke * , 2014 .

[89]  J. Chen,et al.  Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. , 2014, JAMA.

[90]  P. Bath,et al.  Feasibility of an Ambulance-Based Stroke Trial, and Safety of Glyceryl Trinitrate in Ultra-Acute Stroke: The Rapid Intervention With Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824) , 2013, Stroke.

[91]  S. Bergese,et al.  Clevidipine Rapidly and Safely Reduces Blood Pressure in Acute Intracerebral Hemorrhage: The ACCELERATE Trial , 2013, Cerebrovascular Diseases.

[92]  L. Shaw,et al.  Paramedic Initiated Lisinopril For Acute Stroke Treatment (PIL-FAST): results from the pilot randomised controlled trial , 2013, Emergency Medicine Journal.

[93]  A. Demchuk,et al.  The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial , 2013, Stroke.

[94]  M. Wintermark,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[95]  J. Goldstein,et al.  Clinical applications of the computed tomography angiography spot sign in acute intracerebral hemorrhage: a review. , 2012, Stroke.

[96]  A. Demchuk,et al.  Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study , 2012, The Lancet Neurology.

[97]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[98]  J. Hong,et al.  Induced-hypertension in progressing lacunar infarction , 2011, Journal of the Neurological Sciences.

[99]  G. Guyatt,et al.  GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. , 2011, Journal of clinical epidemiology.

[100]  G. Tsivgoulis,et al.  Intravenous Thrombolysis for Acute Ischaemic Stroke: Effective Blood Pressure Control Matters , 2011, International journal of stroke : official journal of the International Stroke Society.

[101]  A. Alexandrov,et al.  Real-Time Hemodynamic Assessment of Downstream Effects of Intracranial Stenoses in Patients with Orthostatic Hypoperfusion Syndrome , 2010, Cerebrovascular Diseases.

[102]  C. Bulpitt,et al.  Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial , 2010, The Lancet Neurology.

[103]  A. Demchuk,et al.  The Intracerebral Haemorrhage Acutely Decreasing Arterial Pressure Trial: ICH ADAPT , 2010, International journal of stroke : official journal of the International Stroke Society.

[104]  A. Alexandrov,et al.  Diagnostic Criteria and Yield of Real-Time Transcranial Doppler Monitoring of Intra-Arterial Reperfusion Procedures , 2010, Stroke.

[105]  A. Qureshi Antihypertensive treatment of acute cerebral hemorrhage* , 2010, Critical care medicine.

[106]  W. Elliott Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial , 2010 .

[107]  A. Alexandrov,et al.  Pre–Tissue Plasminogen Activator Blood Pressure Levels and Risk of Symptomatic Intracerebral Hemorrhage , 2009, Stroke.

[108]  S. Yusuf,et al.  Effect of Telmisartan on Functional Outcome, Recurrence, and Blood Pressure in Patients With Acute Mild Ischemic Stroke: A PRoFESS Subgroup Analysis , 2009, Stroke.

[109]  M. Kaste,et al.  Relationship of Blood Pressure, Antihypertensive Therapy, and Outcome in Ischemic Stroke Treated With Intravenous Thrombolysis: Retrospective Analysis From Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR) , 2009, Stroke.

[110]  C. Jagger,et al.  Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial. , 2009, Health technology assessment.

[111]  Gary A. Ford,et al.  Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) , 2008, Stroke.

[112]  J. Grotta,et al.  Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke. , 2008, Archives of neurology.

[113]  A. Qureshi Acute Hypertensive Response in Patients With Stroke: Pathophysiology and Management , 2008, Circulation.

[114]  C. Weiller,et al.  Cerebral Autoregulation Dynamics in Acute Ischemic Stroke after rtPA Thrombolysis , 2008, Cerebrovascular Diseases.

[115]  Gary A. Ford,et al.  Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. , 2008, Cerebrovascular diseases.

[116]  C. Anderson,et al.  Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial , 2008, The Lancet Neurology.

[117]  A. Rabinstein,et al.  Rapid Blood Pressure Reduction in Acute Intracerebral Hemorrhage: Feasibility and Safety , 2008, Neurocritical care.

[118]  M. Kaste,et al.  Association of Characteristics of Blood Pressure Profiles and Stroke Outcomes in the ECASS-II Trial , 2008, Stroke.

[119]  P. Bath,et al.  Interventions for Deliberately Altering Blood Pressure in Acute Stroke , 2014, The Cochrane database of systematic reviews.

[120]  Eric E. Smith,et al.  Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage , 2007, Neurology.

[121]  John F Potter,et al.  Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up. , 2007, American journal of hypertension.

[122]  A. Alexandrov,et al.  Association of Pretreatment Blood Pressure With Tissue Plasminogen Activator-Induced Arterial Recanalization in Acute Ischemic Stroke , 2007, Stroke.

[123]  A. Divani,et al.  Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. , 2007, The American journal of emergency medicine.

[124]  J. Potter,et al.  Pressor Therapy in Acute Ischemic Stroke: Systematic Review , 2006, Stroke.

[125]  K. Iseki,et al.  Effects of blood pressure levels on case fatality after acute stroke , 2005, Journal of hypertension.

[126]  G. Schroth,et al.  Blood Pressure and Vessel Recanalization in the First Hours After Ischemic Stroke , 2005, Stroke.

[127]  M. Kaste,et al.  Blood pressure, nimodipine, and outcome of ischemic stroke , 2004, Acta neurologica Scandinavica.

[128]  G. Tsivgoulis,et al.  U‐shaped relationship between mortality and admission blood pressure in patients with acute stroke , 2004, Journal of internal medicine.

[129]  Joaquín Serena,et al.  Blood Pressure Decrease During the Acute Phase of Ischemic Stroke Is Associated With Brain Injury and Poor Stroke Outcome , 2004, Stroke.

[130]  A. Alexandrov,et al.  Improving the Predictive Accuracy of Recanalization on Stroke Outcome in Patients Treated With Tissue Plasminogen Activator , 2003, Stroke.

[131]  J. Potter,et al.  Blood pressure in acute stroke. , 2004, Age and ageing.

[132]  J. Oliveira-Filho,et al.  Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset , 2003, Neurology.

[133]  J. Ulatowski,et al.  A Pilot Randomized Trial of Induced Blood Pressure Elevation: Effects on Function and Focal Perfusion in Acute and Subacute Stroke , 2003, Cerebrovascular Diseases.

[134]  H. Diener,et al.  The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors , 2003, Stroke.

[135]  J. Leonardi-Bee,et al.  The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. , 2003, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[136]  N. Wahlgren,et al.  Effects of Blood Pressure Lowering in the Acute Phase of Total Anterior Circulation Infarcts and Other Stroke Subtypes , 2003, Cerebrovascular Diseases.

[137]  P. Sandercock,et al.  Blood Pressure and Clinical Outcomes in the International Stroke Trial , 2002, Stroke.

[138]  F. Buonanno,et al.  A pilot study of drug-induced hypertension for treatment of acute stroke , 2001, Neurology.

[139]  P. Bath,et al.  The Effect of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Blood Pressure and Platelet Function in Acute Stroke , 2001, Cerebrovascular Diseases.

[140]  N. Wahlgren,et al.  Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. , 2000, Stroke.

[141]  K. Welch,et al.  Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1997, Archives of neurology.

[142]  F. Buonanno,et al.  Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. , 1997, Stroke.

[143]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[144]  M. Kaste,et al.  A Randomized, Double‐blind, Placebo‐Controlled Trial of Nimodipine in Acute Ischemic Hemispheric Stroke , 1994, Stroke.

[145]  N. Wahlgren,et al.  Intravenous Nimodipine West European Stroke Trial (INWEST) of Nimodipine in the Treatment of Acute Ischaemic Stroke , 1994 .

[146]  J. Broderick,et al.  Factors Related to Intracranial Hematoma Formation in Patients Receiving Tissue‐Type Plasminogen Activator forAcute Ischemic Stroke , 1994, Stroke.

[147]  J. Marler,et al.  Urgent Therapy for Stroke: Part II. Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes From Onset , 1992, Stroke.

[148]  J. Broderick,et al.  Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes , 1992, Stroke.

[149]  L. Wilkins Clinical Trial of Nimodipine in Acute Ischemic Stroke , 1992 .

[150]  D. Barer,et al.  Low dose β blockade in acute stroke (“BEST” trial): an evaluation , 1988 .

[151]  H. J. Gelmers,et al.  A controlled trial of nimodipine in acute ischemic stroke. , 1988, The New England journal of medicine.

[152]  S. Ebrahim,et al.  Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. , 1988, British medical journal.